Catalyst Wire Dossier Catalyst Wire Dossier

Clevidipine Butyrate Injection

clevidipine butyrate · Nanjing Yoko Biomedical Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Clevidipine Butyrate Injection, covering 2020-12-17 to 2021-09-14. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of Clevidipine Butyrate Injection in the Treatment of Hypertensive Emergency and Sub-emergency [Phase 3]

See pricing